GlassScriptPhysician profile
Kate Margaret Brod
NPI 1639796717
$1,186.51
in general payments reported to CMS, 2019-2025
12 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $410 · 2023: $182 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Inari Medical, INC. | $182.13 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $173.49 | 2025 | Spy-Phi System |
| Davol INC. | $137.00 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $104.87 | 2022 | |
| Merck Sharp & Dohme LLC | $81.07 | 2025 | Lynparza, Keytruda |
| Daiichi Sankyo INC. | $58.18 | 2025 | Enhertu |
| Lilly USA, LLC | $41.25 | 2025 | Jaypirca, Verzenio |
| Astrazeneca Pharmaceuticals LP | $26.73 | 2025 | Enhertu |
| Puma Biotechnology, INC. | $26.13 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.55 | 2025 | |
| Novartis Pharmaceuticals Corporation | $25.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Brod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.